Henry DH - Search Results

1

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Mittelman M, Henry DH, Glaspy JA, Tombak A, Harrup R, Kim I, Mądry K, Grabowska B, Lee T, Modelska K. Mittelman M, et al. Among authors: henry dh. Am J Hematol. 2024 Sep;99(9):1778-1789. doi: 10.1002/ajh.27410. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884137 Clinical Trial.

2

Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.

Henry DH, Glaspy J, Harrup R, Mittelman M, Zhou A, Carraway HE, Bradley C, Saha G, Modelska K, Bartels P, Leong R, Yu KP. Henry DH, et al. Am J Hematol. 2022 Feb 1;97(2):174-184. doi: 10.1002/ajh.26397. Epub 2021 Nov 9. Am J Hematol. 2022. PMID: 34724251 Free article. Clinical Trial.

3

Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.

Glaspy J, Gabrail NY, Locantore-Ford P, Lee T, Modelska K, Samal V, Henry DH. Glaspy J, et al. Among authors: henry dh. Am J Hematol. 2023 May;98(5):703-711. doi: 10.1002/ajh.26865. Epub 2023 Feb 24. Am J Hematol. 2023. PMID: 36710399 Free article. Clinical Trial.

4

A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.

Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J. Auerbach M, et al. Am J Hematol. 2019 Sep;94(9):1007-1014. doi: 10.1002/ajh.25564. Epub 2019 Jul 13. Am J Hematol. 2019. PMID: 31243803 Free PMC article. Clinical Trial.

5

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

Ludwig H, Crawford J, Osterborg A, Vansteenkiste J, Henry DH, Fleishman A, Bridges K, Glaspy JA. Ludwig H, et al. Among authors: henry dh. J Clin Oncol. 2009 Jun 10;27(17):2838-47. doi: 10.1200/JCO.2008.19.1130. Epub 2009 Apr 20. J Clin Oncol. 2009. PMID: 19380447

6

A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.

Birgegård G, Henry D, Glaspy J, Chopra R, Thomsen LL, Auerbach M. Birgegård G, et al. Pharmacotherapy. 2016 Apr;36(4):402-14. doi: 10.1002/phar.1729. Epub 2016 Apr 1. Pharmacotherapy. 2016. PMID: 26927900 Free PMC article. Clinical Trial.

7

Efficacy and safety of ferric carboxymaltose infusion in reducing anemia in patients receiving chemotherapy for nonmyeloid malignancies: A randomized, placebo-controlled study (IRON-CLAD).

Makharadze T, Boccia R, Krupa A, Blackman N, Henry DH, Gilreath JA. Makharadze T, et al. Among authors: henry dh. Am J Hematol. 2021 Dec 1;96(12):1639-1646. doi: 10.1002/ajh.26376. Epub 2021 Nov 19. Am J Hematol. 2021. PMID: 34653287 Free PMC article. Clinical Trial.

8

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

Glaspy J, Crawford J, Vansteenkiste J, Henry D, Rao S, Bowers P, Berlin JA, Tomita D, Bridges K, Ludwig H. Glaspy J, et al. Br J Cancer. 2010 Jan 19;102(2):301-15. doi: 10.1038/sj.bjc.6605498. Epub 2010 Jan 5. Br J Cancer. 2010. PMID: 20051958 Free PMC article.

9

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa.

Glaspy J, Henry D, Patel R, Tchekmedyian S, Applebaum S, Berdeaux D, Lloyd R, Berg R, Austin M, Rossi G; Darbepoetin Alfa 20010162 Study Group. Glaspy J, et al. Eur J Cancer. 2005 May;41(8):1140-9. doi: 10.1016/j.ejca.2005.01.021. Epub 2005 Apr 8. Eur J Cancer. 2005. PMID: 15911237 Clinical Trial.

10

High-molecular weight iron dextran: a wolf in sheep's clothing?

Rodgers GM, Auerbach M, Cella D, Chertow GM, Coyne DW, Glaspy JA, Henry DH. Rodgers GM, et al. Among authors: henry dh. J Am Soc Nephrol. 2008 May;19(5):833-4. doi: 10.1681/ASN.2008030255. Epub 2008 Mar 27. J Am Soc Nephrol. 2008. PMID: 18369084 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters